Pfizer seeks permission to use corona vaccine in India in case of emergency


Bangla Hunt Desk: The Indian unit of the pharmaceutical company Pfizer has applied to the Comptroller General of Indian Medicine (CGMI) for emergency use of the Covina vaccine of Covid-19 made by their UK branch in India. Pfizer made the request after their coroner tickers were approved in Britain and Bahrain.

Official sources said that in an application filed with the drug regulator, the agency had applied for approval to import and distribute the vaccine in the country. Also, under the special provisions of the Drugs and Clinical Trials Rules, 2019, requests have been made to conduct clinical trials on the population of India.

According to a source, Pfizer India had applied to DGCI on December 4 for the use of their corona ticker in India.

The UK on Wednesday granted Pfizer temporary approval for the use of corona tickers. Bahrain on Friday approved Pfizer as the second country in the world after Britain to use the corona vaccine in the country. Pfizer has previously applied for the use of this ticker in the United States.

Pfizer's vaccine needs to be kept at minus 60 degrees Celsius. And that is why the Indian weather will be the biggest challenge to this ticker. The Indian government is looking at the Oxford AstraZeneca ticker. The vaccine is expected to hit the market in the next few months.